BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 31097716)

  • 1. Ciclopirox inhibits Hepatitis B Virus secretion by blocking capsid assembly.
    Kang JA; Kim S; Park M; Park HJ; Kim JH; Park S; Hwang JR; Kim YC; Jun Kim Y; Cho Y; Sun Jin M; Park SG
    Nat Commun; 2019 May; 10(1):2184. PubMed ID: 31097716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus.
    Lam AM; Espiritu C; Vogel R; Ren S; Lau V; Kelly M; Kuduk SD; Hartman GD; Flores OA; Klumpp K
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Hepatitis B Virus Capsid-Targeting Antiviral That Aggregates Core Particles and Inhibits Nuclear Entry of Viral Cores.
    Huber AD; Pineda DL; Liu D; Boschert KN; Gres AT; Wolf JJ; Coonrod EM; Tang J; Laughlin TG; Yang Q; Puray-Chavez MN; Ji J; Singh K; Kirby KA; Wang Z; Sarafianos SG
    ACS Infect Dis; 2019 May; 5(5):750-758. PubMed ID: 30582687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of a novel hepatitis B virus pregenomic RNA encapsidation inhibitor.
    Jo E; Ryu DK; König A; Park S; Cho Y; Park SH; Kim TH; Yoon SK; Ryu WS; Cechetto J; Windisch MP
    Antiviral Res; 2020 Mar; 175():104709. PubMed ID: 31940474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA Variants.
    Lam AM; Ren S; Espiritu C; Kelly M; Lau V; Zheng L; Hartman GD; Flores OA; Klumpp K
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly.
    Wu S; Zhao Q; Zhang P; Kulp J; Hu L; Hwang N; Zhang J; Block TM; Xu X; Du Y; Chang J; Guo JT
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrimidotriazine derivatives as selective inhibitors of HBV capsid assembly.
    Toyama M; Sakakibara N; Takeda M; Okamoto M; Watashi K; Wakita T; Sugiyama M; Mizokami M; Ikeda M; Baba M
    Virus Res; 2019 Oct; 271():197677. PubMed ID: 31376401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle.
    Lahlali T; Berke JM; Vergauwen K; Foca A; Vandyck K; Pauwels F; Zoulim F; Durantel D
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells.
    Huber AD; Wolf JJ; Liu D; Gres AT; Tang J; Boschert KN; Puray-Chavez MN; Pineda DL; Laughlin TG; Coonrod EM; Yang Q; Ji J; Kirby KA; Wang Z; Sarafianos SG
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29669885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsid Assembly Modulators Have a Dual Mechanism of Action in Primary Human Hepatocytes Infected with Hepatitis B Virus.
    Berke JM; Dehertogh P; Vergauwen K; Van Damme E; Mostmans W; Vandyck K; Pauwels F
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids.
    Campagna MR; Liu F; Mao R; Mills C; Cai D; Guo F; Zhao X; Ye H; Cuconati A; Guo H; Chang J; Xu X; Block TM; Guo JT
    J Virol; 2013 Jun; 87(12):6931-42. PubMed ID: 23576513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B Virus Core Protein Dephosphorylation Occurs during Pregenomic RNA Encapsidation.
    Zhao Q; Hu Z; Cheng J; Wu S; Luo Y; Chang J; Hu J; Guo JT
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the multifunctional HBV core protein as a potential cure for chronic hepatitis B.
    Viswanathan U; Mani N; Hu Z; Ban H; Du Y; Hu J; Chang J; Guo JT
    Antiviral Res; 2020 Oct; 182():104917. PubMed ID: 32818519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxethazaine inhibits hepatitis B virus capsid assembly by blocking the cytosolic calcium-signalling pathway.
    Zhang L; Liu C; Xiao Y; Chen X
    J Gen Virol; 2016 May; 97(5):1198-1209. PubMed ID: 26838678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication.
    Dong C; Qu L; Wang H; Wei L; Dong Y; Xiong S
    Antiviral Res; 2015 Jun; 118():110-7. PubMed ID: 25843425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of hepatitis B virus core protein residues critical for capsid assembly, pgRNA encapsidation and resistance to capsid assembly modulators.
    Luo Y; Cheng J; Hu Z; Ban H; Wu S; Hwang N; Kulp J; Li Y; Du Y; Chang J; Viswanathan U; Guo JT
    Antiviral Res; 2021 Jul; 191():105080. PubMed ID: 33933516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulators of HBV capsid assembly as an approach to treating hepatitis B virus infection.
    Cole AG
    Curr Opin Pharmacol; 2016 Oct; 30():131-137. PubMed ID: 27636324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization and Synthesis of Pyridazinone Derivatives as Novel Inhibitors of Hepatitis B Virus by Inducing Genome-free Capsid Formation.
    Lu D; Liu F; Xing W; Tong X; Wang L; Wang Y; Zeng L; Feng C; Yang L; Zuo J; Hu Y
    ACS Infect Dis; 2017 Mar; 3(3):199-205. PubMed ID: 27989113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical characterization of AB-506, an inhibitor of HBV replication targeting the viral core protein.
    Mani N; Cole AG; Phelps JR; Ardzinski A; Burns R; Chiu T; Cuconati A; Dorsey BD; Evangelista E; Fan K; Guo F; Harasym TO; Kadhim S; Kowalski R; Kultgen SG; Lee ACH; Li AH; Majeski SA; Miller A; Pasetka C; Reid SP; Rijnbrand R; Micolochick Steuer HM; Stever K; Tang S; Teng X; Wang X; Sofia MJ
    Antiviral Res; 2022 Jan; 197():105211. PubMed ID: 34826506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fragment-based drug discovery developed on ciclopirox for inhibition of Hepatitis B virus core protein: An in silico study.
    Mohebbi A; Ghorbanzadeh T; Naderifar S; Khalaj F; Askari FS; Sammak AS
    PLoS One; 2023; 18(5):e0285941. PubMed ID: 37196004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.